Samuel Oschin Cancer Center at Cedars-Sinai — Los Angeles, California

Samuel Oschin Cancer Center at Cedars-Sinai is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Samuel Oschin Cancer Center at Cedars-Sinai has participated in 1 clinical trials.

Therapeutic areas: Resectable Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma.

Sponsors: Lei Zheng.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Samuel Oschin Cancer Center at Cedars-Sinai?

Samuel Oschin Cancer Center at Cedars-Sinai has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Samuel Oschin Cancer Center at Cedars-Sinai conducted?

Samuel Oschin Cancer Center at Cedars-Sinai has 1 clinical trials on record. Their work covers Resectable Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma.

Is Samuel Oschin Cancer Center at Cedars-Sinai accredited by Crixeo Health?

Samuel Oschin Cancer Center at Cedars-Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Samuel Oschin Cancer Center at Cedars-Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.